• Explore /
  • Poster
  • / Avelumab as single agent for patients with metastatic or locally advanced urothelial cancer PD-L1+ unfit for cisplatin: The ARIES study.

Avelumab as single agent for patients with metastatic or locally advanced urothelial cancer PD-L1+ unfit for cisplatin: The ARIES study.

Abstract Poster

Authors

null

Roberto Iacovelli

Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

Roberto Iacovelli , Sebastiano Buti , Consuelo Buttigliero , Rocco De Vivo , Claudia Caserta , Francesco Ferraú , Luca Galli , Valentino Martelli , Cristina Masini , Rodolfo Mattioli , Sara Merler , Laura Milesi , Emanuele Naglieri , Riccardo Ricotta , Mimma Rizzo , Cosimo Sacco , Daniele Santini , Rosa Tambaro , Elena Verri , Matteo Santoni

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03891238

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr TPS596)

Abstract #

TPS596

Poster Bd #

N14

Abstract Disclosures

Similar Posters

First Author: Matt D. Galsky

First Author: Igor Tsaur

First Author: Roberto Iacovelli

First Author: Alfonso Gomez De Liano Lista